Scott Garland
DirectoratOlema Pharmaceuticals· In the 2025 proxy
Scott Garland sits on 8 public boards.
Boards1
- Enliven TherapeuticsDirector · -1 yr on the boardNot independentNominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Olema PharmaceuticalsPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role +19%
- Enliven TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrNo stock prices for these years
- LB Pharmaceuticals, Inc.Public company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Olema Pharmaceuticals, Inc.Public company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- ALX OncologyPublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Day One Biopharmaceuticals, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Calithera Biosciences, Inc.Public company · 3 yr
- Director2020 – 2023 · 3 yrNo stock prices for these years
- Directors for Karyopharm Therapeutics Inc.Public company · 6 yr
- Director2014 – 2020 · 6 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?